LYMPHANGIOLEIOMYOMATOSIS Experts

We have collected the completed list of expert related to LYMPHANGIOLEIOMYOMATOSIS using public data available on different databases.

LYMPHANGIOLEIOMYOMATOSIS Experts map



If you find this map or researchers for LYMPHANGIOLEIOMYOMATOSIS useful, maybe you will be also interested in other rare diseases proffesionals like our hereditary spastic paraplegia expert list ,or our beta-thalassemia expert list

LYMPHANGIOLEIOMYOMATOSIS Experts list

Pr Thomas O. WAGNER

 FRANKFURT AM MAIN. GERMANY

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project - Coordinator of expert centre network - Coordinator of research network

  • Research area/topic:
    ENCE CF-LAM-LTX: European networks of centres of expertise for CF (Cystic Fibrosis), LAM (Lymphangioleiomyomatosis), and LTX (Lung Transplantation)
  • Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
    Zentrum der Inneren Medizin, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
  • t.wa****@***uni_frankfurt.de
Complete Info

Pr Judit E PONGRÁCZ

 PECS. HUNGARY

  Investigator of research project

  • Research area/topic:
    Studying the role of Wnt signaling to develop novel therapeutic targets and diganostic markers in LAM
  • Faculty of Medicine, University of Pécs
  • pongracz********@***.hu
Complete Info

Dr Sergio HARARI

 MILANO. ITALY

  Coordinator of expert centre - Principal investigator of clinical trial - Coordinator of research network

  • Research area/topic:
    Il Polmone.it - Malattie Rare Polmonari
  • Ospedale San Giuseppe
    Ospedale San Giuseppe
  • sha****@***olmone.it
Complete Info

Ms Mahitha GUMMADI

 BIRMINGHAM. UNITED KINGDOM

  Investigator of research project

  • Research area/topic:
    Use of cleaved collagen motifs, VEGF-D and clinical phenotype to predict disease progression in lymphangioleiomyomatosis (LAM)
  • Queen Elizabeth Medical Centre, Queen Elizabeth Hospital
    St John's Institute of Dermatology, St Thomas' Hospital
    D Floor, South Block, Queen's Medical Centre
    Southampton General Hospital
  • m.gu*****@***t.nhs.uk
Complete Info

Ms Mahitha GUMMADI

 LONDON. UNITED KINGDOM

  Investigator of research project

  • Research area/topic:
    Use of cleaved collagen motifs, VEGF-D and clinical phenotype to predict disease progression in lymphangioleiomyomatosis (LAM)
  • Queen Elizabeth Medical Centre, Queen Elizabeth Hospital
    St John's Institute of Dermatology, St Thomas' Hospital
    D Floor, South Block, Queen's Medical Centre
    Southampton General Hospital
  • m.gu*****@***t.nhs.uk
Complete Info

Ms Mahitha GUMMADI

 NOTTINGHAM. UNITED KINGDOM

  Investigator of research project

  • Research area/topic:
    Use of cleaved collagen motifs, VEGF-D and clinical phenotype to predict disease progression in lymphangioleiomyomatosis (LAM)
  • Queen Elizabeth Medical Centre, Queen Elizabeth Hospital
    St John's Institute of Dermatology, St Thomas' Hospital
    D Floor, South Block, Queen's Medical Centre
    Southampton General Hospital
  • m.gu*****@***t.nhs.uk
Complete Info

Pr Simon JOHNSON

 NOTTINGHAM. UNITED KINGDOM

  Coordinator of expert centre - Clinical expert - Investigator of research project

  • Research area/topic:
    Use of cleaved collagen motifs, VEGF-D and clinical phenotype to predict disease progression in lymphangioleiomyomatosis (LAM)
  • D Floor, South Block, Queen's Medical Centre
    Queens Medical Centre, Queen's Medical Centre
  • simon.*******@***tingham.ac.uk
Complete Info

Ms Mahitha GUMMADI

 SOUTHAMPTON. UNITED KINGDOM

  Investigator of research project

  • Research area/topic:
    Use of cleaved collagen motifs, VEGF-D and clinical phenotype to predict disease progression in lymphangioleiomyomatosis (LAM)
  • Queen Elizabeth Medical Centre, Queen Elizabeth Hospital
    St John's Institute of Dermatology, St Thomas' Hospital
    D Floor, South Block, Queen's Medical Centre
    Southampton General Hospital
  • m.gu*****@***t.nhs.uk
Complete Info

Other experts list that you may find interesting:

All the contact information provided is based on public data available in orpha.net.